Navigation Links
Wilson Sonsini Goodrich & Rosati Expands IP Litigation Practice

PALO ALTO, Calif., May 9, 2011 /PRNewswire/ -- Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, is pleased to announce that Jeffrey Alan Hovden has become a partner at the firm. An experienced intellectual property litigator and counselor with particular expertise in pharmaceuticals, Hovden formerly was a partner at Katten Muchin Rosenman. He will be based in the firm's New York office.


"In recent years, I'm proud to say that the firm has established one of the top generic pharmaceutical practices in the nation, with a unique integrated approach across a broad array of legal disciplines," said CEO Steve Bochner. "Jeff is a terrific IP litigator with exactly the type of knowledge and experience that our pharmaceutical clients most need and value. He will help us further grow the practice and lends additional strength to our overall East Coast litigation capabilities."

Hovden specializes in patent litigation with a focus on pharmaceutical cases under the Hatch-Waxman Act and within the biotechnology industry more broadly. He has litigated numerous patent infringement and invalidity actions, including many cases involving top-selling, global prescription drugs for both generic and name-brand pharmaceutical companies. In addition to his robust litigation practice, Hovden advises clients on their intellectual property portfolios. He has extensive experience with the Food, Drug, and Cosmetic Act's drug-approval provisions and their attendant regulations, and provides infringement, validity, and due diligence opinions. In addition, Hovden has experience with copyrights, particularly ones involving functional works, and counsels his biotechnology clients regarding licensing matters.

Prior to his tenure at Katten, Hovden was a partner at Frommer Lawrence & Haug. Conversant in Japanese, he received his J.D. from the Columbia University School of Law in 1993 and a B.A., summa cum laude, with majors in biology and philosophy from the University of Minnesota in 1988.

About Wilson Sonsini Goodrich & Rosati

Celebrating its 50th anniversary in 2011, Wilson Sonsini Goodrich & Rosati offers a broad range of services and legal disciplines focused on serving the principal challenges faced by the management and boards of directors of business enterprises. The firm is nationally recognized as a leader in the fields of corporate governance and finance, mergers and acquisitions, private equity, securities litigation, employment law, intellectual property, and antitrust, among many other areas of law. With long-standing roots in Silicon Valley, Wilson Sonsini Goodrich & Rosati has offices in Austin, Hong Kong, New York, Palo Alto, San Diego, San Francisco, Seattle, Shanghai, and Washington, D.C. For more information, please visit

SOURCE Wilson Sonsini Goodrich & Rosati
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PDL BioPharma Appoints Caroline Krumel as Vice President of Finance and Thanks Karen Wilson for her Contributions
2. Goodrich to Showcase Advanced Helicopter Systems at Heli-Expo
3. Lexicon Pharmaceuticals Announces Webcast of 2011 Annual R&D Day
4. American Regent Initiates Nationwide Voluntary Recall of Caffeine & Sodium Benzoate Injection, USP 250 mg/mL, 2 mL Single Dose Vial Due to Visible Particulates
5. ThermoGenesis Reports Third Quarter Fiscal 2011 Results; Major Progress Achieved in China & India
6. Pharmaceutical Litigation Partner James Stronski Joins Crowell & Moring
7. Reportlinker Adds European Market for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011
8. NMT Medical, Inc. Assigned All Its Assets to Joseph F. Finn, Jr., C.P.A. of the Firm Finn, Warnke & Gayton, LLP on April 20, 2011
9. Robbins & Myers Completes Sale of Romaco Businesses
10. Diplomat Specialty Pharmacys Hagerman Named Grant Thornton Leader & Innovator of the Year
11. Allina Hospitals & Clinics Makes Long Term Commitment to IOD
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015  The American ... and Gynecologists (ACOG), and the March of Dimes ... Protecting Our Infants Act of 2015 ... number of newborns born exposed to drugs, such ... the bill,s introduction, all three organizations have worked ...
(Date:11/25/2015)... On Tuesday, November 24, 2015, the ... Wright Medical Technology, Inc. for product liability and ... implant device, awarded $11 million in favor of ... and three days of deliberations, the jury found ... designed and unreasonably dangerous, and that Wright Medical ...
(Date:11/25/2015)... AVIV, Israel , November 25, 2015 ... (NASDAQ: KTOV ) (TASE: KTOV), a biopharmaceutical company ... simultaneous treatment of various clinical conditions, today announced the ... 3,158,900 American Depository Shares ( ADSs ), each representing ... purchase up to 3,158,900 ADSs. The ADSs and warrants ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... Dr. Thomas Dunlap and ... and Dr. Tucker Bierbaum with Emergency Medicine at St., Joseph Health System’s Santa ... and Sepsis conditions present in similar ways and require time-critical intervention to avoid large ...
(Date:11/26/2015)... ON (PRWEB) , ... November 26, 2015 , ... ... of a real-time eReferral system for diagnostic imaging in the Waterloo region. Using ... BMD and Nuclear Medicine tests directly from their electronic medical record (EMR) without ...
(Date:11/26/2015)... Mass. (PRWEB) , ... November 26, 2015 , ... ... thorough second medical opinion process, participated in the 61st annual Employee Benefits Conference. ... Plans and took place Sunday, November 8th through Wednesday, November 11th, 2015. The ...
(Date:11/25/2015)... ... 25, 2015 , ... As part of a global movement ... volunteers together who want to combine talents and resources to help create sustainable ... process. The non-profit launched its first major fundraiser on November 6, 2015 at ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical Director at the ... loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared for safety and ... hair, without the need for surgery, prescription pills, or topical foams. , “Capillus272™ ...
Breaking Medicine News(10 mins):